Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01303939 · ClinicalTrials.gov registry record · NA
Does Glaucoma Cause Loss of Brain Function?
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01303939 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 37 participants.
The verdict
NCT01303939, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if glaucoma is associated with neurodegenerative changes in areas of the brain other than the occipital lobe. This will help guide the direction of further research in the use of neuroprotective agents in preventing or controlling such changes. The final goal is to improve the quality of life for patients with glaucoma.
Interventions
- DIAGNOSTIC_TEST magnetic resonance imaging (MRI) of the brain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01303939
The ClinicalTrials.gov registry entry for NCT01303939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which magnetic resonance imaging (MRI) of the brain is the first listed.
NCT01303939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01303939 about?
NCT01303939 is a clinical study titled "Does Glaucoma Cause Loss of Brain Function?". The purpose of the study is to determine if glaucoma is associated with neurodegenerative changes in areas of the brain other than the occipital lobe. This will help guide the direction of further research in the use of neuroprotective agents in preventing or controlling such changes. The final goal...
What is the current status of trial NCT01303939?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2010-08. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01303939?
The interventions under investigation include: magnetic resonance imaging (MRI) of the brain (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01303939?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.